Initial results of Sana Biotechnology’s new gene-editing technique demonstrate that transplanted islet cells successfully produced insulin in a man with type 1 diabetes – without the need for ...

The biotechnology company, which develops genetically engineered silkworms, says it is moving toward commercial production of ...

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

Diabetes is one of the most common chronic disorders across the globe. As such, an increasing number of people are worried about developing insulin resistance, which is a foundational component of the ...

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs were later found to promote weight loss and improve ...

A new study from Stanford Medicine reports that combining blood stem cell and pancreatic islet cell transplants from immunologically mismatched donors can prevent or even reverse Type 1 diabetes in ...